How to Do Expanded Algorithm

Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Ne…

Aurinia Pharmaceuticals Inc. today announced the initiation of PRESERVE, a Phase 4, multicenter study investigating the ...

Some results have been hidden because they may be inaccessible to you